Effect of Parathyroid Hormone on Bone Metabolism - Mechanics of Cellular Bone Remodeling - page 167

3. Wang Y. N. Mathematical modeling of bone remodeling under mechanical,
electromagnetic fields at the cellular level. PhD thesis, Australian National
University (2010).
4. Frost H. M. Bone remodeling dynamics, vol. 59. Springfield, IL: Charles C Thomas
Co. (1963).
5. Robling A. G., Castillo A. B., Turner C. H. Biomechanical and molecular
regulation of bone remodeling. Annual Review of Biomedical Engineering
8: 455-498 (2006).
6. Parfitt A. M. Osteonal and hemi-osteonal remodeling: The spatial and temporal
framework for signal traffic in adult human bone. Journal of Cellular Biochemistry
55 (3): 273-286 (1994).
7. Hadjidakis D. J., Androulakis I. I. Bone remodeling. Annals of the New York
Academy of Sciences 1092 (1): 385-396 (2006).
8. Kroll M. Parathyroid hormone temporal effects on bone formation and
resorption. Bulletin of Mathematical Biology 62 (1): 163-188 (2000).
9. Datta N. S., Abou-Samra A. B. PTH and PTHrP signaling in osteoblasts. Cellular
Signaling 21 (8): 1245-1254 (2009).
10. Neer R. M., Arnaud C. D., Zanchetta J. R., Prince R., Gaich G. A., Reginster J. Y.,
Hodsman A. B., et al. Effect of parathyroid hormone (1-34) on fractures and bone
mineral density in postmenopausal women with osteoporosis. New England
Journal of Medicine 344 (19): 1434-1441 (2001).
11. Jilka R. L., Weinstein R. S., Bellido T., Roberson P., Parfitt A. M., Manolagas S. C.
Increased bone formation by prevention of osteoblast apoptosis with parathyroid
hormone. Journal of Clinical Investigation 104 (4): 439-446 (1999).
12. Tam C. S., Heersche J. N. M., Murray T. M., Parsons J. A. Parathyroid
hormone stimulates the bone apposition rate independently of its resorptive
action—Differential effects of intermittent and continuous administration.
Endocrinology 110 (2): 506-512 (1982).
13. Khosla S., Westendorf J. J., Oursler M. J. Building bone to reverse osteoporosis
and repair fractures. Journal of Clinical Investigation 118 (2): 421-428 (2008).
14. Rubin M. R., Bilezikian J. P. New anabolic therapies in osteoporosis. Endocrinology
& Metabolism Clinics of North America 32 (1): 285-307 (2003).
15. Lee S. K., Lorenzo J. A. Parathyroid hormone stimulates TRANCE and inhibits
osteoprotegerin messenger ribonucleic acid expression in murine bone
marrow cultures: Correlation with osteoclast-like cell formation. Endocrinology
140 (8): 3552-3561 (1999).
16. Fu Q., Jilka R. L., Manolagas S. C., O'Brien C. A. Parathyroid hormone stimulates
receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression
via protein kinase A activation of cAMP-response element-binding protein.
Journal of Biological Chemistry 277 (50): 48868-48875 (2002).
17. Rattanakul C., Lenbury Y., Krishnamara N., Wolwnd D. J. Modeling of bone
formation and resorption mediated by parathyroid hormone: Response to
estrogen/PTH therapy. Biosystems 70 (1): 55-72 (2003).
18. Komarova S. V., Smith R. J., Dixon S. J., Sims S. M., Wahl L. M. Mathematical
model predicts a critical role for osteoclast autocrine regulation in the control of
bone remodeling. Bone 33 (2): 206-215 (2003).
19. Komarova S. V. Mathematical model of paracrine interactions between
osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on
bone. Endocrinology 146 (8): 3589-3595 (2005).